Alpha Tau Medical Ltd-cl A (DRTS)
$2.28
Performance
- $2.28$2.39$2.28
0.0%
Downside
Day's Volatility :4.6%
Upside
4.6%
- $1.75$3.90$2.28
23.25%
Downside
52 Weeks Volatility :55.13%
Upside
41.54%
Returns
| Period | Alpha Tau Medical Ltd-cl A | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | 3.64% | 5.0% | 0.0% |
6 Months | -20.28% | 5.9% | 0.0% |
1 Year | -35.77% | 16.6% | 0.0% |
3 Years | -76.92% | 18.9% | -21.4% |
Highlights
Market Capitalization | 159.4M |
Book Value | $1.06 |
Earnings Per Share (EPS) | -0.4 |
Wall Street Target Price | 9.25 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -21.92% |
Return On Equity TTM | -33.17% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -35.2M |
Diluted Eps TTM | -0.4 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.48 |
EPS Estimate Next Year | -0.49 |
EPS Estimate Current Quarter | -0.11 |
EPS Estimate Next Quarter | -0.12 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 305.7%
Technicals Summary
Sell
Neutral
Buy
Alpha Tau Medical Ltd-cl A is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Alpha Tau Medical Ltd-cl A | 1.79% | -20.28% | -35.77% | -76.92% | -77.43% |
 Regeneron Pharmaceuticals, Inc. | -11.53% | 7.92% | 21.76% | 83.48% | 256.87% |
 Novo Nordisk A/s | -12.73% | -9.68% | 25.05% | 134.03% | 343.37% |
 Alnylam Pharmaceuticals, Inc. | 5.86% | 71.74% | 59.21% | 32.07% | 248.13% |
 Vertex Pharmaceuticals Incorporated | -3.35% | 12.64% | 28.18% | 152.92% | 164.64% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Alpha Tau Medical Ltd-cl A | NA | NA | NA | -0.48 | -0.33 | -0.22 | NA | 1.06 |
Regeneron Pharmaceuticals, Inc. | 26.81 | 26.81 | 1.38 | 45.05 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 38.76 | 38.76 | 1.75 | 3.39 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.49 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.55 | 0.32 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Alpha Tau Medical Ltd-cl A | Buy | $159.4M | -77.43% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $111.6B | 256.87% | 26.81 | 32.04% |
Novo Nordisk A/s | Buy | $512.4B | 343.37% | 38.76 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $34.4B | 248.13% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $117.5B | 164.64% | 32.84 | -4.74% |
Insights on Alpha Tau Medical Ltd-cl A
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 51.5% return, outperforming this stock by 88.9%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 32.1% return, outperforming this stock by 109.0%
Institutional Holdings
Easterly Investment Partners.
0.40%Hoylecohen, LLC
0.38%HighTower Advisors, LLC
0.33%Corbin Capital Partners LP
0.14%Satovsky Asset Management LLC
0.08%Private Advisor Group, LLC
0.07%
Company Information
alpha tau medical (http://www.alphataumedical.com/) focuses on research, development and commercialization of alpha dart (diffusing alpha-emitters radiation therapy) for the treatment of solid cancer tumors. alpha dart technology, initially developed at tel aviv university, was shown to be effective and safe for treating different types of cancer in multiple animal studies. the company is running its first clinical trial in several sites in the eu. breakthrough technology for cancer treatment the alpha dart breakthrough technology utilizes alpha radiation to treat cancer and enables highly potent and conformal radiotherapy. alpha dart treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha emitting atoms into the tumor.
Organization | Alpha Tau Medical Ltd-cl A |
Employees | 121 |
CEO | Mr. Uzi Sofer |
Industry | Healthcare |
